Pyrazolopyrimidines as CRF antagonists
US6218397A · kind A · utility
11Cited by
13References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 4, 1998 |
| Grant date | Apr 17, 2001 |
| Priority date | — |
| Expiry date | Sep 4, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of the formula: ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein PA1 A is NR.sub.1 R.sub.2, CR.sub.1 R.sub.2 R.sub.11, or C(.dbd.CR.sub.1 R.sub.12)R.sub.2, NHCR.sub.1 R.sub.2 R.sub.11, OCR.sub.1 R.sub.2 R.sub.11, SCR.sub.1 R.sub.2 R.sub.11, NHNR.sub.1 R.sub.2, CR.sub.2 R.sub.11 NHR.sub.1, CR.sub.2 R.sub.11 OR.sub.1, CR.sub.2 R.sub.11 SR.sub.1 or C(O)R.sub.2 ; wherein the rest of the variables are herein below defined, used for inflammatory disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.